Clinical trial
Non-Invasive Biomarkers in Prostate Cancer Disease Management
NCT06144619 is registered in ClinicalTrials.gov with H. Lee Moffitt Cancer Center and Research Institute as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Non-Invasive Biomarkers in Prostate Cancer Disease Management
- Lead sponsor
- H. Lee Moffitt Cancer Center and Research Institute
- Phase
- Observational
- Overall status
- Suspended
- Start date
- November 21, 2023
- Completion date
- January 31, 2029
- Enrollment
- 500 (estimated)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
prostate cancer